A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent

Şükran Poyrazoğlu, Vivian Hwa, Firdevs Baş, Andrew Dauber, Ron Rosenfeld, Feyza Darendeliler

Research output: Contribution to journalArticle

Abstract

Acid-labile subunit (ALS) forms ternary complexes with insulin like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) and is essential for normal circulating IGF-1 levels. The IGFALS gene encodes the ALS and mutations in IGFALS cause ALS deficiency. We describe a patient with ALS deficiency with a novel homozygous frameshift mutation in IGFALS presenting with short stature and delayed puberty but ultimately achieving an adult height (AH) comparable to his target height (TH). A 15.25 year old boy presented with short stature (149.9 cm, -3.04 standard deviation score). The patient had a low circulating IGF-1 concentration, extremely low IGFBP-3 concentration, insulin resistance and osteopenia. The peak growth hormone (GH) response to GH stimulation test was high (31.6 ng/mL). Sequencing of IGFALS revealed a novel, homozygous, frameshift mutation (p.Ser555Thrfs.19). His mother and elder sister were heterozygous carriers. Although he had delayed puberty and short stature at the onset of puberty, he reached his TH and an AH similar to those of his heterozygous mother and sister. The heterozygous carriers had normal or low IGF-1 concentrations and low IGFBP-3 concentrations but not as markedly low as that of the patient. They had normally timed puberty, insulin metabolism and bone mineral density (BMD). The phenotype of ALS deficiency is quite variable. Despite short stature and delayed puberty, patients can achieve normal pubertal growth and AH. ALS deficiency may cause osteopenia and hyperinsulinemia. Heterozygous carriers may have normal prenatal growth, puberty, insulin metabolism and BMD.

Original languageEnglish (US)
Pages (from-to)432-438
Number of pages7
JournalJournal of clinical research in pediatric endocrinology
Volume11
Issue number4
DOIs
StatePublished - Nov 22 2019

Fingerprint

Somatomedins
Delayed Puberty
Insulin-Like Growth Factor Binding Protein 3
Mutation
Acids
Puberty
Genes
Frameshift Mutation
Metabolic Bone Diseases
Bone Density
Growth Hormone
Siblings
Mothers
Insulin
Hyperinsulinism
Growth
Insulin Resistance
Phenotype

Keywords

  • acid-labile subunit deficiency
  • IGFALS gene mutation
  • primary IGF-1 deficiency
  • Short stature

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent. / Poyrazoğlu, Şükran; Hwa, Vivian; Baş, Firdevs; Dauber, Andrew; Rosenfeld, Ron; Darendeliler, Feyza.

In: Journal of clinical research in pediatric endocrinology, Vol. 11, No. 4, 22.11.2019, p. 432-438.

Research output: Contribution to journalArticle

Poyrazoğlu, Şükran ; Hwa, Vivian ; Baş, Firdevs ; Dauber, Andrew ; Rosenfeld, Ron ; Darendeliler, Feyza. / A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent. In: Journal of clinical research in pediatric endocrinology. 2019 ; Vol. 11, No. 4. pp. 432-438.
@article{396149e61ead4e79a1b408c8092851d2,
title = "A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent",
abstract = "Acid-labile subunit (ALS) forms ternary complexes with insulin like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) and is essential for normal circulating IGF-1 levels. The IGFALS gene encodes the ALS and mutations in IGFALS cause ALS deficiency. We describe a patient with ALS deficiency with a novel homozygous frameshift mutation in IGFALS presenting with short stature and delayed puberty but ultimately achieving an adult height (AH) comparable to his target height (TH). A 15.25 year old boy presented with short stature (149.9 cm, -3.04 standard deviation score). The patient had a low circulating IGF-1 concentration, extremely low IGFBP-3 concentration, insulin resistance and osteopenia. The peak growth hormone (GH) response to GH stimulation test was high (31.6 ng/mL). Sequencing of IGFALS revealed a novel, homozygous, frameshift mutation (p.Ser555Thrfs.19). His mother and elder sister were heterozygous carriers. Although he had delayed puberty and short stature at the onset of puberty, he reached his TH and an AH similar to those of his heterozygous mother and sister. The heterozygous carriers had normal or low IGF-1 concentrations and low IGFBP-3 concentrations but not as markedly low as that of the patient. They had normally timed puberty, insulin metabolism and bone mineral density (BMD). The phenotype of ALS deficiency is quite variable. Despite short stature and delayed puberty, patients can achieve normal pubertal growth and AH. ALS deficiency may cause osteopenia and hyperinsulinemia. Heterozygous carriers may have normal prenatal growth, puberty, insulin metabolism and BMD.",
keywords = "acid-labile subunit deficiency, IGFALS gene mutation, primary IGF-1 deficiency, Short stature",
author = "Ş{\"u}kran Poyrazoğlu and Vivian Hwa and Firdevs Baş and Andrew Dauber and Ron Rosenfeld and Feyza Darendeliler",
year = "2019",
month = "11",
day = "22",
doi = "10.4274/jcrpe.galenos.2019.2018.0301",
language = "English (US)",
volume = "11",
pages = "432--438",
journal = "JCRPE Journal of Clinical Research in Pediatric Endocrinology",
issn = "1308-5727",
publisher = "Galenos Yayincilik",
number = "4",

}

TY - JOUR

T1 - A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent

AU - Poyrazoğlu, Şükran

AU - Hwa, Vivian

AU - Baş, Firdevs

AU - Dauber, Andrew

AU - Rosenfeld, Ron

AU - Darendeliler, Feyza

PY - 2019/11/22

Y1 - 2019/11/22

N2 - Acid-labile subunit (ALS) forms ternary complexes with insulin like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) and is essential for normal circulating IGF-1 levels. The IGFALS gene encodes the ALS and mutations in IGFALS cause ALS deficiency. We describe a patient with ALS deficiency with a novel homozygous frameshift mutation in IGFALS presenting with short stature and delayed puberty but ultimately achieving an adult height (AH) comparable to his target height (TH). A 15.25 year old boy presented with short stature (149.9 cm, -3.04 standard deviation score). The patient had a low circulating IGF-1 concentration, extremely low IGFBP-3 concentration, insulin resistance and osteopenia. The peak growth hormone (GH) response to GH stimulation test was high (31.6 ng/mL). Sequencing of IGFALS revealed a novel, homozygous, frameshift mutation (p.Ser555Thrfs.19). His mother and elder sister were heterozygous carriers. Although he had delayed puberty and short stature at the onset of puberty, he reached his TH and an AH similar to those of his heterozygous mother and sister. The heterozygous carriers had normal or low IGF-1 concentrations and low IGFBP-3 concentrations but not as markedly low as that of the patient. They had normally timed puberty, insulin metabolism and bone mineral density (BMD). The phenotype of ALS deficiency is quite variable. Despite short stature and delayed puberty, patients can achieve normal pubertal growth and AH. ALS deficiency may cause osteopenia and hyperinsulinemia. Heterozygous carriers may have normal prenatal growth, puberty, insulin metabolism and BMD.

AB - Acid-labile subunit (ALS) forms ternary complexes with insulin like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) and is essential for normal circulating IGF-1 levels. The IGFALS gene encodes the ALS and mutations in IGFALS cause ALS deficiency. We describe a patient with ALS deficiency with a novel homozygous frameshift mutation in IGFALS presenting with short stature and delayed puberty but ultimately achieving an adult height (AH) comparable to his target height (TH). A 15.25 year old boy presented with short stature (149.9 cm, -3.04 standard deviation score). The patient had a low circulating IGF-1 concentration, extremely low IGFBP-3 concentration, insulin resistance and osteopenia. The peak growth hormone (GH) response to GH stimulation test was high (31.6 ng/mL). Sequencing of IGFALS revealed a novel, homozygous, frameshift mutation (p.Ser555Thrfs.19). His mother and elder sister were heterozygous carriers. Although he had delayed puberty and short stature at the onset of puberty, he reached his TH and an AH similar to those of his heterozygous mother and sister. The heterozygous carriers had normal or low IGF-1 concentrations and low IGFBP-3 concentrations but not as markedly low as that of the patient. They had normally timed puberty, insulin metabolism and bone mineral density (BMD). The phenotype of ALS deficiency is quite variable. Despite short stature and delayed puberty, patients can achieve normal pubertal growth and AH. ALS deficiency may cause osteopenia and hyperinsulinemia. Heterozygous carriers may have normal prenatal growth, puberty, insulin metabolism and BMD.

KW - acid-labile subunit deficiency

KW - IGFALS gene mutation

KW - primary IGF-1 deficiency

KW - Short stature

UR - http://www.scopus.com/inward/record.url?scp=85075814311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075814311&partnerID=8YFLogxK

U2 - 10.4274/jcrpe.galenos.2019.2018.0301

DO - 10.4274/jcrpe.galenos.2019.2018.0301

M3 - Article

C2 - 30717585

AN - SCOPUS:85075814311

VL - 11

SP - 432

EP - 438

JO - JCRPE Journal of Clinical Research in Pediatric Endocrinology

JF - JCRPE Journal of Clinical Research in Pediatric Endocrinology

SN - 1308-5727

IS - 4

ER -